Clinical trial
A Randomized, Opened, Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Young Adults
NCT02203357 is registered in ClinicalTrials.gov with Peking University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Opened, Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Young Adults
- Lead sponsor
- Peking University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2014
- Completion date
- December 31, 2016
- Enrollment
- 353 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.